MedTrace Logo

Study of the Nevisense Device to Assess Atypical Skin Lesions

NCT04705168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2025-11-20

No results posted yet for this study

Summary

The purpose of this study is to find out whether the Nevisense device can provide useful information about atypical moles to complement the usual assessments done during routine screening for melanoma. Assessing particpants' moles with the Nevisense device may help improve screening methods for the early detection of melanoma in people with atypical mole syndrome.

Conditions

  • Nevus
  • Multiple Nevi
  • Large Acquired Nevi
  • Skin Lesion

Interventions

DIAGNOSTIC_TEST

Nevisense electrical impedance spectroscopy

Each participants will undergo Nevisense electrical impedance spectroscopy in order to characterize the electrical impedance spectroscopy scores of nevi in patients with ≥ 100 nevi on the entire cutaneous surface and at least three large acquired nevi (LAN) \> 5 mm in diameter

Sponsors & Collaborators

Principal Investigators

  • Ashfaq Marghoob, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2025-11-18
Completion
2025-11-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04705168 on ClinicalTrials.gov